Skip to content

Medical-device intelligence

Eps Bio Technology Corp.: FDA clearances and recalls

Research Eps Bio Technology Corp. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

25 clearance records and 0 recall records in the covered releases, across 1 source company names and 3 product codes. Dated history runs from Apr 29, 2005 to Oct 23, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202610

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

25 matching records
Device / recordCompany in FDA recordSourceSource date
EASYMAX Voice Blood Glucose Monitoring SystemK261293 · NBWEPS Bio Technology Corp.510(k)Oct 23, 2026FDA decision date
EASYMAX Tag Self-Monitoring Blood Glucose SystemK201258 · NBWEps Bio Technology Corp.510(k)Sep 1, 2021FDA decision date
MDT2 BLE Self-Monitoring Blood Glucose SystemK190189 · NBWEps Bio Technology Corp.510(k)Nov 1, 2019FDA decision date
EasyMax BT Self-Monitoring Blood Glucose SystemK182057 · NBWEps Bio Technology Corp.510(k)Aug 24, 2018FDA decision date
EGV1.1 SELF MONITORING BLOOD GLUCOSE SYSTEM AND EGV1.1 PRO MONITORING BLOOD GLUCOSE SYSTEMK133537 · LFREps Bio Technology Corp.510(k)Apr 28, 2014FDA decision date
EM40 SELF-MONITORING BLOOD GLUCOSE SYSTEMK133389 · NBWEps Bio Technology Corp.510(k)Apr 15, 2014FDA decision date
EMV3.1 PRO BLOOD GLUCOSE SYSTEM AND EMV3.1 SELF MONITORING BLOOD GLUCOSE SYSTEMK133647 · NBWEps Bio Technology Corp.510(k)Feb 27, 2014FDA decision date
EASYMAX MU SELF MONITORING BLOOD GLUCOSE SYSTEM, EASYMAX MU PRO SELF MONITORING BLOOD GLUCOSE SYSTEMK121207 · LFREps Bio Technology Corp.510(k)May 18, 2012FDA decision date
EM50 SELF MONITORING BLOOD GLUCOSE SYSTEMK113243 · LFREps Bio Technology Corp.510(k)Mar 28, 2012FDA decision date
EME SELF MONITORING BLOOD GLUCOSE SYSTEM, EME PRO SELF MONITORING BLOOD GLUCOSE SYSTEMK112901 · LFREps Bio Technology Corp.510(k)Dec 23, 2011FDA decision date
EMV3 SELF MONITORING BLOOD GLUCOSE SYSTEM, EMV3 PRO SELF MONITORING BLOOD GLUCOSE SYSTEMK111728 · CGAEps Bio Technology Corp.510(k)Sep 16, 2011FDA decision date
EM44 SELF MONITORING BLOOD GLUCOSE SYSTEM, EM44 PRO SELF MONITORING BLOOD GLUCOSE SYSTEMK112272 · LFREps Bio Technology Corp.510(k)Sep 7, 2011FDA decision date
EASYMAX T1 SELF MONITORING BLOOD GLUCOSE SYSTEM, MODEL EPS10042K102345 · NBWEps Bio Technology Corp.510(k)Jun 21, 2011FDA decision date
EG V1 (BL) SELF MONITORING GLUCOSE TEST SYSTEM MODEL: EPS10017K101037 · LFREps Bio Technology Corp.510(k)May 23, 2011FDA decision date
EASYPLUS MINI R9N SELF MONITORING BLOOD GLUCOSE SYSTEM MODEL EPS10031K101457 · NBWEps Bio Technology Corp.510(k)Jul 1, 2010FDA decision date
EASYMAX V SELF MONITORING BLOOD GLUCOSE SYSTEMK092894 · NBWEps Bio Technology Corp.510(k)Feb 24, 2010FDA decision date
EASYPLUS MINI MASTERDRIVER SELF MONITORING BLOOD GLUCOSE SYSTEM, MODEL EPS09009K092887 · NBWEps Bio Technology Corp.510(k)Oct 21, 2009FDA decision date
EASYPLUS MINI R13N SELF MONITORING BLOOD GLUCOSE SYSTEMK091481 · NBWEps Bio Technology Corp.510(k)Aug 18, 2009FDA decision date
GLUCOMANAGER DATA MANAGEMENT SOFTWAREK091229 · NBWEps Bio Technology Corp.510(k)Jul 31, 2009FDA decision date
EASYPLUS MINI R2N SELF MONITORING GLUCOSE TEST SYSTEMK081796 · NBWEps Bio Technology Corp.510(k)Jan 23, 2009FDA decision date
EASYMAX N SELF MONITORING BLOOD GLUCOSE SYSTEM, MODEL: EPS08008K083099 · NBWEps Bio Technology Corp.510(k)Jan 16, 2009FDA decision date
EASYMAX SELF MONITORING GLUCOSE TEST SYSTEM, MODEL # EPS08005K082121 · CGAEps Bio Technology Corp.510(k)Sep 17, 2008FDA decision date
EASYPLUS MINI SELF MONITORING GLUCOSE TEST SYSTEM, MODELS R1 AND R2K070053 · NBWEps Bio Technology Corp.510(k)Dec 3, 2007FDA decision date
EASYPLUS SELF MONITORING GLUCOSE TEST SYSTEM, MODEL EPS04014K061992 · CGAEps Bio Technology Corp.510(k)Sep 19, 2006FDA decision date
EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEMK043245 · CGAEps Bio Technology Corp.510(k)Apr 29, 2005FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗